SARS-CoV Spike 抗体
(5 references)Quick Overview for SARS-CoV Spike 抗体 (ABIN2452119)
抗原
See all SARS-CoV Spike (SARS-CoV S) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
产品特性
- Monoclonal antibody 3A2 recognizes the spike protein consisting of 1181 amino acids, which migrates at 200 kDa position on SDS-PAGE due to its glyco-chains.
-
纯化方法
- Purified
-
过滤
- Sterile filtered
-
亚型
- IgG2b kappa
-
-
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 1124-1140) antibody
SARS-CoV S 适用: SARS Coronavirus (SARS-CoV) WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 401-500) antibody (AbBy Fluor® 488)SARS-CoV S 适用: SARS Coronavirus (SARS-CoV), Virus WB 宿主: 兔 Polyclonal AbBy Fluor® 488
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 19-35) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) WB 宿主: 小鼠 Monoclonal unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 288-303) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 19-35) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) ELISA, WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 755-769) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) WB 宿主: 兔 Polyclonal unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 13-42) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) WB 宿主: 兔 Polyclonal RB3977-3978 unconjugated
anti-SARS-Coronavirus Spike Protein (SARS-CoV S) (AA 532-562) antibodySARS-CoV S 适用: SARS Coronavirus (SARS-CoV) WB 宿主: 兔 Polyclonal RB3983-3984 unconjugated
-
-
应用备注
-
1) Western blotting: 0. 1~0. 3 g/mL
2) Immunofluoresece staining (IHC)
3) ELISA Isoform: IgG2b (kappa) -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS, 50 % glycerol
-
储存液
- Azide free
-
储存条件
- -20 °C/-80 °C
-
储存方法
- -20 C (For long term storage: -80 C)
-
-
-
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
: "Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats." in: BMC infectious diseases, Vol. 21, Issue 1, pp. 871, (2021) (PubMed).
: "Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients." in: Journal of clinical microbiology, (2020) (PubMed).
: "The molecular biology of SARS coronavirus." in: Annals of the New York Academy of Sciences, Vol. 1102, pp. 26-38, (2007) (PubMed).
: "Establishment of Vero E6 cell clones persistently infected with severe acute respiratory syndrome coronavirus." in: Microbes and infection / Institut Pasteur, Vol. 7, Issue 15, pp. 1530-40, (2005) (PubMed).
-
: "Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening"." in: PloS one, Vol. 16, Issue 4, pp. e0250319, (2021) (PubMed).
-
- SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))
-
别名
- SARS-CoV Spike
-
物质类
- Viral Protein
-
背景
- A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and directly binds to the virus receptor, ACE2 (Angiotensin-Converting Enzyme 2). Hybridoma 3A2 has been isolated by injecting mouse with SARS virus and as the clone which produces antibody that specifically reacts with the virus-infected cell, in the laboratory of Prof. K. Ikuta of Osaka University.
抗原
-
